Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
BioData Catalyst is a cloud-based ecosystem with data and analytic capabilities to advance research on heart, lung, blood, and sleep diseases, disorders, and conditions.
CEAL is helping communities hardest hit by COVID-19. Learn more about CEAL and its programs.
Cardiac arrest is a life-threatening condition in which the heart suddenly stops beating.
Interstitial lung diseases (ILDs) are a group of more than 200 different disorders that cause scarring in the lungs and make it hard to breathe.
Sleep deprivation and deficiency are conditions that occur when you don't get enough good quality sleep when your body needs it. This can lead to physical and mental health problems.
Pneumonia is a lung infection that causes the air sacs to fill up with fluid or pus. This can make it hard to breathe.
Sickle cell disease causes the red blood cells to have a sickle or crescent shape instead of a disc shape. The sickle-shaped cells can block blood vessels and lead to serious health problems.
Platelet disorders are conditions in which the number of platelets in your blood is either too low or too high, or your platelets don’t work properly. This can cause problems with bleeding or forming too many blood clots.
The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.